Process Development Scientists are responsible for designing and optimizing the processes used to manufacture pharmaceutical products at scale. Their work bridges the gap between laboratory research and large-scale production, ensuring that drugs can be produced efficiently, safely, and cost-effectively. These scientists focus on optimizing formulations, refining production techniques, and improving the consistency and quality of drug products. Their expertise is crucial in identifying the most efficient methods to scale up production without compromising product integrity or regulatory compliance. They also focus on improving the reproducibility of processes, ensuring that every batch produced meets the same high standards of quality and safety. In addition, process development scientists evaluate new technologies and techniques, such as continuous manufacturing and automation, to increase productivity and reduce manufacturing costs. Their work is key to reducing the time-to-market for new drugs, making therapies available to patients more quickly and efficiently.
They work closely with engineers and other technical experts to develop processes that can be replicated in large manufacturing facilities. Process development scientists also play a key role in troubleshooting production issues and ensuring that production processes remain adaptable to meet evolving industry needs and regulations. By optimizing manufacturing protocols, these scientists help streamline the drug development process, reduce production costs, and ensure timely delivery of medications to the market. Their contributions are essential in bringing innovative pharmaceutical therapies to patients worldwide.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia